chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a RN concerning a 13 year old male student with no allergies and no past medical history who on 06/27/1995 was vaccinated SQ in the LA with a first dose  of varicella virus vaccine live. There was no illness at the time of vaccination. There was no concomitant medication. On 06/22/2004, the pt developed a random lesion or pimple but, on 06/27/04, became full blown  with over 100 lesions on the face, stomach, back, and a few on the extremities. The pt was afebrile per the mother. Unspecified medical attention was sought, but the pt was out of town and had not been seen by the physician. The pt was treated with calamine + camphor + pramoxine hydrochloride ( Aveeno) soap and diphenhydramine hydrochloride ( Benadryl). The pt was healing well and recovered on 07/08/2004. There was no known exposure to chicken pox. A product quality complaint was not involved. Addtional information is expected.
Information has been received from a health professional from an OB/GYN office concerning a female who on 28-JAN-2008 was vaccinated IM with a 0.5 ml first dose of GARDASIL. On 02-Apr-2008 the patient was vaccinated IM with a 0.5 ml second dose of GARDASIL. On 07-APR-2008 the patient developed rash on her arms and legs. At the time of reporting the patient's rash was spreading. The patient went to primary care physician. At the time of reporting the patient had not recovered. Additional information has been requested.
My son second set of shots cause him to have a severe reaction that lead, to a lost of words, lost of cooing sound, a language impairment and since 6 months old difficulties with speech.
Pfizer COVID vaccine EUA: Fully vaccinated person reported to employer having a (+) COVID-19 test on 080821 after symptom onset on 080721 (type/duration of symptoms unknown) .
Pt recvd 1st dose of Hep B vax 3SEP91 & that evening pt exp swelling & soreness of arm @ inject site; also devel t101; 4SEP91 devel rash, hives, flu-like illness consisting of h/a, joint aches, & myalgia tx DPH; also exp nausea;
Immediately after receiving Tdap, Menactra, and HPV  at 3:15 pm patient reported feeling dizzy, weak.  Pale, sweating, no loss of contiousness, pt. placed in supine position on floor with legs elevated.  BP 98/68, p. 88, 3:20 pm reported feeling better, 98/64, p. 84, color improved and able to sit upright. 4 pm, released in care of brother,  pt. advised no driving today, to ER increase symptoms.  Verbalized understanding.
Initial report was received from a consumer through another manufacturer on 06 December 2012 under service request, number 1-5728549810. A female patient had received a "subdermal one injection in each arm" of DIPHTHERIA, TETANUS AND PERTUSSIS VACCINE (manufacturer, lot number and exact date of administration not reported) sometime in 2011. A couple hours of getting the vaccine, the patient fell on the floor, her stomach was hurting very badly and she was nauseated. A physician told her to place on wash cloth on her forehead and go to bed. The patient remained in bed the entire weekend except she had to keep getting up due to diarrhea. The patient stated it might have been due to eating some fish that could have been not cooked properly and it was perhaps a type of food poisoning. The patient "tested positive for compo factor bacterium in her colon that could have been caused from the food she ate." A few days later, the patient broke out in a rash all over her body that has lasted for about five months and is still present. The patient also experienced constipation due to the colon bacteria that lasted a long time. The patient stated this happened another time prior to vaccination as she has irritable bowel syndrome. Treatment included cold wash cloth on forehead, bed rest, antibiotics and cortisone injections. Laboratory diagnostic testing included "colonoscopy, allergy studies and lab work - different variety recently". The patient had a history of irritable bowel syndrome with constipation, auto immune disease, depression, gastritis, GERD, arthritis and carpal tunnel. Allergies included sulfa, the myacin family of meds, bees, "some type of cream that goes in the vagina" and "iodine stuff they put in the machines for radiographic x-rays". Concomitant medications included WELLBUTRIN and PROZAC. Outcome was not recovered. Documents held by sender: None.
Positive for Covid; Lethargy; Fever; Redness and pain at the injection site; Redness and pain at the injection site; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Positive for Covid), LETHARGY (Lethargy), PYREXIA (Fever), VACCINATION SITE ERYTHEMA (Redness and pain at the injection site) and VACCINATION SITE PAIN (Redness and pain at the injection site) in a 36-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045J21A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Pfizer (Lot No EP7533) on 02-Apr-2021 and Pfizer (Lot No ER8735) on 23-Apr-2021. Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer.    On 27-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced LETHARGY (Lethargy), PYREXIA (Fever), VACCINATION SITE ERYTHEMA (Redness and pain at the injection site) and VACCINATION SITE PAIN (Redness and pain at the injection site). On 14-Jun-2022, the patient experienced COVID-19 (Positive for Covid). In 2021, LETHARGY (Lethargy), PYREXIA (Fever), VACCINATION SITE ERYTHEMA (Redness and pain at the injection site) and VACCINATION SITE PAIN (Redness and pain at the injection site) had resolved. At the time of the report, COVID-19 (Positive for Covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Jun-2022, SARS-CoV-2 test: (Positive) Positive.         Concomitant medications were not reported.  Patient had regular symptoms observed like fever, lethargy, redness and pain at the injection site for a couple of days. Patient had no allergic reactions in any of the vaccines before. Patient had symptoms as coughing and shortness of breath. Patient was not hospitalized or anything but had a rough case for a week and had to use an inhaler and other medications to improve coughing and shortness of breath.   This case was linked to MOD-2022-657728 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-Oct-2022: Follow-up received contains no new information
Covid-19 positive; Running nose; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Running nose) and SARS-COV-2 TEST POSITIVE (Covid-19 positive) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced RHINORRHOEA (Running nose). On 25-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Covid-19 positive). At the time of the report, RHINORRHOEA (Running nose) and SARS-COV-2 TEST POSITIVE (Covid-19 positive) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Mar-2021, SARS-CoV-2 test positive: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant information  provided. No Treatment information  provided
Red, inflamed area approximately 2 inches wide by 4 inches long on patient's arm developed after the vaccine was given. Inflamed area was approximately 2 inches below the site of the vaccine. Dr. prescribed a MEDROL dose pak a day after vaccine was given.
Dizzy,Fever, Disoriented, (expected: arm soreness, heat, swelling administered frozen pea bag)   rash on forearms,, not hives, passed out for 9 hours    I thought I would just relax with my frozen peas and watch tv.   9 hours later, I was slumped on the couch, tv had not been  turned on , I was fully dressed including shoes, no blanket or pillow, very cold all  the lights that I had turned on were still on and it was 5:10 in the am  I had not brushed my teeth or taken evening  medication.   I had warmed left overs in the oven thinking I might just be hungry.   Oven was off but oven door was open  food was uneaten except for a couple of bites.    I live alone.    I still work and manage everything on my own.
This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 03-DEC-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L023385, expiration date: 25-JUN-2017 (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Severe headache...still lasting today 11/09. Same thing happened last year after receiving flu shot.  Last year the headache lasted one month!!!
No adverse event; First dose was administered Dec-2020 and second dose was administered on Mar-2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose was administered Dec-2020 and second dose was administered on Mar-2021) and NO ADVERSE EVENT (No adverse event) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis (MODERATE TO SEVERE RHEUMATOID ARTHRITIS).   In December 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In March 2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose was administered Dec-2020 and second dose was administered on Mar-2021). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose was administered Dec-2020 and second dose was administered on Mar-2021) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Oct-2021, Blood test: increased Sedimentation rate..         Concomitant product use was not provided by the reporter.  On 28-Oct-2021, blood work showed increased sedimentation rate. On 28 Oct 2021 she had taken flu shot. No treatment information was provided. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   This case was linked to MOD-2021-623528, MOD-2021-628642 (Patient Link).   Reporter did not allow further contact
This spontaneous report was received from a 60 year old female consumer, reporting on herself, with unspecified hypersensitivity to MIGRANAL. There was not pertinent medical history. On 21-DEC-2015, the patient was vaccinated without prescription from a physician, with ZOSTAVAX, (dosage, route, lot# and expiration date were not reported). There was not concomitant therapy. On approximately 22-DEC-2015, (reported as "after one or two days") the patient experienced musculoskeletal discomfort, reported as "constant pressure on her back", then on approximately 24-DEC-2015, (reported as "on Thursday or Friday"), the patient experienced herpes zoster, reported as "shingles". The patient sought medical attention by a physician visit and VALTREX was prescribed. There were not laboratories studies performed. The outcome of herpes zoster and musculoskeletal discomfort was reported as recovering at the time of this report, as the patient just started medication on 30-DEC-2015. Additional information is not expected because the reporter did not provided details to be contacted.
Client received 1st dose of Pfizer on 4/5/21. 2nd dose scheduled 4/26/21. Client arrived to clinic today after driving 2 hours away. There was no adverse reaction but patient received vaccine 5 days earlier than the recommended scheduled date for a second dose. Pt understands this was not ideal but insisted on receiving second dose because she drove 2 hours away
Moderna COVID-19 Vaccine EUA One week after the injection,  a red, inflamed, raised itchy rash  appeared at the injection site. This rash has persisted for two days, with no change.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. On 27-JUL-2016, the patient was vaccinated with improperly stored M-M-R II lot # L029266 (dose and route of administration were not reported). This is one of several reports received from the same source. Additional information has been requested.
Tested positive during ER visit for asthma exacerbation 3 days PTA but pt unaware of result; was dc home with oral steroid and Zpack. Presented with SOB and hypoxia, dx with COVID w/ asthma exac. Vaccinated 6/2021 but no booster yet. O2, steroids, nebs, vit-c, zince, vit-D. Able to wean to RA and was discharged home.
Adverse event: Vaccine administered 6 days after beyond use date and less effective. Treatment: Pt is receiving another dose in office as recommended by Pfizer and the state of MA.
Abnormal menstrual bleeding. I had completed my period on October 17 2021 and should not have been bleeding again for another 2 months per my birth control method. The abnormal bleeding started suddenly one morning and lasted about a week. I had cramping, back pain, and blood clotting during this abnormal bleeding.  It did not affect my daily activities, but it caused extra fatigue and pain to flare up in other parts of my body which usually doesn't happen on my regular period. This is a similar experience to what happened twice after my 2nd Pfizer dose.
HPI: Patient is a pleasant 29-year-old male presents to clinic with 11-day history of fatigue, intermittent nausea, dry mouth, headache, weakness, feeling of dehydration and feeling feverish without fever.  Patient states he is sleeping very poorly.  He states he has had increased water intake but feels dehydrated and as though his urine looks different from his normal as well as smells differently.  Patient had his second Pfizer COVID-19 vaccination on 22 February in his right arm and he states that approximately 6 to 12 hours after this injection he started to feel unwell.  Patient has a history of SVT and he states that he feels almost constantly as though he is in the aftermath of an SVT episode.  He has not had an episode for 1 to 2 months.  His resting heart rate is typically in the 45-50 range.  Patient denies any ear pain, throat pain, myalgia, loss of sense of taste or smell, cough, dyspnea, abdominal pain or chest pain.  He had attempted to see his primary care provider today.  His nurse at had recommended that he seek care here as his provider was not available..
This spontaneous report as received from a physician refers to an unspecified number of patients of unknown age and gender. On an unknown dates, multiple unspecified patients were administered PNEUMOVAX23 (dose, route of administration, lot# and expiration date were not provided) that was stored improperly. No adverse effects were reported. Additional information has been requested.
Moderna Covid-19 Vaccine EUA - Symptom-Red ring around right arm injection site that was swollen and itchy. Duration: 48 hours. No treatment. Swelling and red ring disappeared.
I received 4th Covid-19 shot (2nd booster) in my left arm; however now my right arm  injection site where I received the 3rd vaccine (on September 30) is hurting!
late local reaction of erythema and itching that began 10 days post vaccine. Area measures 8 cm x 5 cm. Non tender. Firm. Warm. treatment with ice, tylenol and anti itch cream.
Constant muscle pain at and around the area of covid-19 vaccine  injection. It impacts me from freely and fully moving my arm, (left arm only as to this day), and is accompanied by variable pain, weakness,  and gives me the impression of having dead cells in that particular area. Sometimes I have to use the right hand to completely lift the left arm, which is painful. I hoped that it will go away, but I am experiencing the same to the present time .
approx 8 hrs p/vax fever 104.4 R, fussy but consolable; 5NOV92 10AM t102.8, rt thigh tender, not red, smiling @ times; 1130AM t103 R, 105.2 noon; 1PM sl redness & tenderness @ inject site-rt thigh; also vomiting;
01/01/23 presents toED for "diarrhea" "weakness" "cough". PMHx of "hypertension, breast cancer, DM type II"
About a month ago was feeling lethargic noticed spots on my feet. I went to my Oncologist stated it was Petechiae and had a bone marrow done was diagnosed with ITP (immune disorder where body is killing my platelets). My doctor is uncertain why I'm dealing with this still dealing with today. As of today I'm on steroids and supplements.
1st dose on 09/16/2018, 2nd dose not received; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 63-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingrix (received 1st dose on 16th Sep 2023, with batch number 3NY58 and expiry date 7th Mar 2021).   On an unknown date, the patient not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: 1st dose on 09/16/2018, 2nd dose not received). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt date: 06-Mar-2023 The registered pharmacist (RPH) reported that the patient had not received 2nd dose. The reporter consented to follow up. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination; Sender's Comments:  US-GSK-US2023035585:Same reporter
This case was reported by a healthcare professional (certified medical assistant) and described the occurrence of injection site soreness in a 49-year-old female subject who was vaccinated with INFANRIX (GlaxoSmithKline). On 22 August 2013 the subject received 1st dose of INFANRIX (.5 ml, unknown route, left arm) and experienced overdose and inappropriate age at vaccine administration. Per the reporter, an "adult female mistakenly vaccinated with INFANRIX instead of BOOSTRIX." The subject received more antigen than indicated by BOOSTRIX. The subject was older than the indicated age for INFANRIX. On 22 August 2013, less than one day after vaccination with INFANRIX, the subject experienced injection site soreness. The reporter stated that the subject "called office to report more soreness than expected" at the injection site. No additional details were provided. At the time of reporting the outcome of the event was unspecified.
Pt recv vax on 10/22/98; on 10/29/98 pt exp pneumonia; tx=antibiotics
from patient: I got my 1st dose and waited the 15 minutes, feeling fine. When I got in the car and started driving home I began to notice that my face was slightly numb (Iike I'd had too much novicaine).  This was maybe 20-25 minutes after the dose.  When I was home I also noticed that the back of my throat felt a little swollen.  This probably lasted for a couple hours.
Fever up to 100.5 degrees, aches, loss of appetite, lethargy Subsided after 36 hrs No treatment sought
25 doses of expired Moderna Covid-19 vaccine were administered to patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patients.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-May-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patients.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patients.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information was provided.
Injection site swelling begun 6 hours post injection. Redness and Warm to touch started 16 hours post injection. All three symptoms are current present 32 hours post injection
Acute headache, acute right upper quadrant and epigastric abdominal pain, Abdominal distension, nausea,  musculoskeletal pain, chills, dizziness
blood shot eye/Blood shot eye on same side that she got vaccine; This is a spontaneous report from a contactable consumer reporting for herself..   A 81-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Right on 08May2021 (Batch/Lot Number: EW0168) as  single dose for covid-19 immunisation  .  Medical history included ongoing gastrooesophageal reflux disease , hypertension , ongoing anxiety. The patient received the first dose of BNT 162B2 vaccine on 27Mar2021 and experienced a fall. Concomitant medications included omeprazole (OMEPRAZOLE) taken for gastrooesophageal reflux disease from an unspecified start date and ongoing.  The patient experienced blood shot eye/blood shot eye on same side that she got vaccine  on 11May2021 with outcome of not recovered.  Follow up information has been requested.
Fever over 100 degrees within 24 hours of administration; Is bivalent: False, Dose number: 5; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60-year-old male patient received BNT162b2 (BNT162B2), on 08Oct2022 at 14:30 as dose 5 (booster), single (Lot number: CZH9703) at the age of 60 years, in right arm for covid-19 immunisation. The patient didn't receive BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5). The patient's relevant medical history included: "Diabetes" (unspecified if ongoing); "High blood pressure" (unspecified if ongoing); "Known allergies: Yes" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete;  unknown manufacturer), for Covid-19 immunization; Covid-19 vaccine (Dose 3 (Booster); unknown manufacturer), for Covid-19 immunization; Covid-19 vaccine (Dose 4 (Booster); unknown manufacturer), for Covid-19 immunization. The following information was reported: WRONG PRODUCT ADMINISTERED (non-serious) with onset 08Oct2022 at 14:30, outcome "unknown", described as "Is bivalent: False, Dose number: 5"; PYREXIA (non-serious) with onset 09Oct2022, outcome "recovering", described as "Fever over 100 degrees within 24 hours of administration". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia.  \Additional information: The patient did not receive any other vaccines within 4 week prior vaccination. The patient had not been diagnosed with COVID-19 prior vaccination and had not been tested for COVID-19 since vaccination.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
25OCT95 pt recv vax & devel shrill uncontrollable cry for 2 days;t103 R 26OCT & 27OCT95;croup 3-4 wk a/vax;well day of vax;croupy cough 27OCT95;PMC notified;
Patient c/o whole body rash  on 12/ 15 after recieving pfizer on 12/13/21. Patient seen by primary care center on 12/15/21 given benedryl.